MedPath

Vinblastine Sulfate

vinBLAStine Sulfate

Approved
Approval ID

f073b58e-56d6-4c8d-a2ce-b37719402d77

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2019

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

VINBLASTINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-278
Application NumberANDA089515
Product Classification
M
Marketing Category
C73584
G
Generic Name
VINBLASTINE SULFATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 31, 2019
FDA Product Classification

INGREDIENTS (4)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
VINBLASTINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: N00W22YO2B
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vinblastine Sulfate - FDA Drug Approval Details